| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.36▲ | 2.38▼ | 2.37▼ | 2.37▼ | 2.38▼ |
| MA10 | 2.37▼ | 2.37▼ | 2.39▼ | 2.32▲ | 2.77▼ |
| MA20 | 2.37▼ | 2.40▼ | 2.40▼ | 2.35▲ | 2.76▼ |
| MA50 | 2.40▼ | 2.38▼ | 2.36▲ | 2.83▼ | 2.72▼ |
| MA100 | 2.40▼ | 2.34▲ | 2.28▲ | 2.79▼ | 2.79▼ |
| MA200 | 2.38▼ | 2.31▲ | 2.54▼ | 2.64▼ | 5.91▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | -0.005▼ | -0.010▼ | 0.042▲ | -0.095▼ |
| RSI | 45.174▼ | 43.720▼ | 47.642▼ | 45.300▼ | 43.606▼ |
| STOCH | 11.806▼ | 47.681 | 15.491▼ | 72.801 | 18.214▼ |
| WILL %R | -70.000 | -86.957▼ | -90.323▼ | -31.481 | -80.000▼ |
| CCI | -46.797 | -86.442 | -82.597 | 67.553 | -97.909 |
| MA | $NRXP Price Crossed Below MA(7) | Set Alert |
|
Wednesday, December 03, 2025 11:54 AM
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, said it amended its Investigational New Drug filing for NRX-101 to include use of the drug in combination with ...
|
|
Wednesday, December 03, 2025 08:30 AM
Austin, Texas, United States, December 3rd, 2025, FinanceWire NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, said ...
|
|
Wednesday, December 03, 2025 05:02 AM
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, today announced that it has amended its Investigational New Drug filing for NRX-101 (D-cycloserine/lurasidone) to ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/12/25 | 2.42 | 2.42 | 2.35 | 2.36 | 205,420 |
| 04/12/25 | 2.42 | 2.51 | 2.36 | 2.44 | 356,710 |
| 03/12/25 | 2.27 | 2.41 | 2.22 | 2.41 | 338,456 |
| 02/12/25 | 2.45 | 2.53 | 2.24 | 2.27 | 990,095 |
| 01/12/25 | 2.43 | 2.45 | 2.33 | 2.39 | 547,435 |
| 28/11/25 | 2.50 | 2.51 | 2.36 | 2.45 | 143,043 |
| 26/11/25 | 2.19 | 2.3709 | 2.16 | 2.34 | 356,303 |
| 25/11/25 | 2.24 | 2.25 | 2.15 | 2.18 | 135,191 |
| 24/11/25 | 2.13 | 2.25 | 2.1208 | 2.24 | 262,925 |
| 21/11/25 | 2.00 | 2.16 | 1.99 | 2.13 | 438,295 |
|
|
||||
|
|
||||
|
|